Diagnosed mild cognitive impairment due to Alzheimer's disease with PET biomarkers of beta amyloid and neuronal dysfunction.

The aim of this study is to identify mild cognitive impairment (MCI) due to Alzheimer's disease (AD) using amyloid imaging of beta amyloid (Aβ) deposition and FDG imaging of reflecting neuronal dysfunction as PET biomarkers. Sixty-eight MCI patients underwent cognitive testing, [11C]-PIB PET an...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Shizuo Hatashita, Hidetomo Yamasaki
Format: article
Langue:EN
Publié: Public Library of Science (PLoS) 2013
Sujets:
R
Q
Accès en ligne:https://doaj.org/article/b8b5f29771d046d29bf3c95786f80641
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!